Abstract:Alzheimer’s disease (AD) is a complex neurodegenerative disease characterized by progressive amyloid and tau pathology. Quantifying and classifying AD pathology across the human brain is challenging due to its large size and expertise needed for critical evaluation of the morphological variety in structure types (e.g. diffuse vs dense plaques, neurofibrillary tangles, neuropil threads, etc.). High‐throughput microscopy imaging and artificial intelligence allow for large‐scale, quantitative ‘digital pathology’ surveys. Due to their structural differences, distinct pathological aggregates in microscopy images can be identified and quantified by trained artificial neural networks (Tang et al 2019). However, current approaches do not incorporate anatomical segmentation to map the distribution of AD pathology across whole tissue sections. Understanding where and when AD pathology is distributed across different brain regions is critical to defining cell type susceptibility to neurodegeneration. This project’s goal was to create a combined neural network classification and segmentation quantification approach to generate anatomically‐accurate pathology maps of the human hippocampus and investigate the spatial distribution of distinct types of pathology. Whole slide images of 4G8 and Gallyas stained coronal tissue sections from the USC ADRC Neuropathology Core were imaged using a slide scanning microscope (29 patients with low, intermediate, or high AD stages). 4G8 sections were manually annotated and segmented using the Allen Human Brain Atlas into thirteen layered hippocampal subregions and delineated using Quantitative Imaging Toolkit (QIT). The machine learning toolkit Ilastik was utilized to quantify and classify 4G8 amyloid staining (dense vs diffuse plaques) and Gallyas (neurofibrillary tangles) within each hippocampal subregion and overlaid to segmentation maps. In the hippocampus, we found diffuse amyloid pathology increased more rapidly across progressive AD stages compared to dense amyloid plaques or tau neurofibrillary tangles. The ratio of diffuse/dense labeling was highest in the presubiculum and parasubiculum in high AD patients. Patient APOE4 genotype also significantly increased the fraction of diffuse amyloid labeling in high AD patients. Integrating machine learning quantification and classification approaches with anatomical segmentation maps allows for rapid characterization of AD pathology across hippocampal subregions and provides new insights into AD progression across the brain.

Neuropathologic and proteomic analysis of human hippocampal CA1 pyramidal neuron sublayers in human Alzheimer disease

Hippocampal CA1 Pyramidal Neurons Display Sublayer and Circuitry Dependent Degenerative Expression Profiles in Aged Female Down Syndrome Mice

Quantitative Assessment of Hippocampal Tau Pathology in AD and PART

Spatial proteomics of hippocampal subfield-specific pathology in Alzheimer's disease and primary age-related tauopathy

Single-nucleus and spatial transcriptomic profiling of human temporal cortex and white matter reveals novel associations with AD pathology

Spatial Dissection of the Distinct Cellular Responses to Normal Aging and Alzheimer′s Disease in Human Prefrontal Cortex at Single-Nucleus Resolution

Spatial Dissection of the Distinct Cellular Responses to Normal Aging and Alzheimer's Disease in Human Prefrontal Cortex at Single-Nucleus Resolution

Combined segmentation and classification of Alzheimer’s disease pathology distribution within human hippocampal subregions

Accumulation of pTau231 at the Postsynaptic Density in Early Alzheimer's Disease

Piecing it together: atrophy profiles of hippocampal subfields relate to cognitive impairment along the Alzheimer's disease spectrum

Super-Resolution Imaging Uncovers Nanoscale Tau Aggregate Hyperphosphorylation Patterns in Human Alzheimer’s Disease Brain Tissue

Dysregulation of Neuropeptide and Tau Peptide Signatures in Human Alzheimer's Disease Brain

Expression Profiling of Precuneus Layer III Cathepsin D‐immunopositive Pyramidal Neurons in Mild Cognitive Impairment and Alzheimer's Disease: Evidence for Neuronal Signaling Vulnerability

Oligomeric, phosphorylated, and truncated tau and spliceosome pathology within the entorhinal-hippocampal connectome across stages of Alzheimer's disease

Subcellular proteomics and iPSC modeling uncover reversible mechanisms of axonal pathology in Alzheimer's disease

Neuron-specific alterations in signal transduction pathways associated with Alzheimer's disease.

Layer‐specific Microstructural Patterns of Anterior Hippocampus in Alzheimer's Disease with Ex Vivo Diffusion MRI at 14.1 T

A cell autonomous regulator of neuronal excitability modulates tau in Alzheimer's disease vulnerable neurons

Altered synaptic plasticity at hippocampal CA1-CA3 synapses in Alzheimer's disease: integration of amyloid precursor protein intracellular domain and amyloid beta effects into computational models

Discrepancy of synaptic and microtubular protein phosphorylation in the hippocampus of APP/PS1 and MAPT×P301S transgenic mice at the early stage of Alzheimer's disease

The Hippocampal Subfield Volume Reduction and Plasma Biomarker Changes in Mild Cognitive Impairment and Alzheimer's Disease